Triplex formation with 2′-O,4′-C-ethylene-bridged nucleic acids (ENA) having C3′-endo conformation at physiological pH

被引:52
|
作者
Koizumi, M [1 ]
Morita, K
Daigo, M
Tsutsumi, S
Abe, K
Obika, S
Imanishi, T
机构
[1] Sankyo Co Ltd, Exploratory Chem Res Labs, Tokyo 1408710, Japan
[2] Sankyo Co Ltd, Biomed Res Labs, Tokyo 1408710, Japan
[3] Sankyo Co Ltd, Pharmacokinet & Drug Delivery Res Labs, Tokyo 1408710, Japan
[4] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka 5650871, Japan
关键词
D O I
10.1093/nar/gkg416
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antigenes, which are substances that inhibit gene expression by binding to double-stranded DNA (dsDNA) in a sequence-specific manner, are currently sought for the treatment of various gene-related diseases. As such antigenes, we developed new nuclease-resistant oligopyrimidine nucleotides that are partially modified with 2'-O, 4'-C-ethylene nucleic acids (ENA), which are constrained in the C3'-endo conformation and can form a triplex with dsDNA at physiological pH. It was found that these oligonucleotides formed triplexes similarly to those partially modified with 2'-O, 4'-C-methylene nucleic acids (2', 4'-BNA or LNA), as determined by UV melting analyses, electromobility shift assays, CD spectral analyses and restriction enzyme inhibition assays. In our studies, oligonucleotides fully modified with ENA have delta torsion angle values that are marginally higher than those of 2', 4'-BNA/LNA. ENA oligonucleotides present in 10-fold the amount of dsDNA were found to be favorable in forming triplexes. These results provide useful information for the future design of triplex-forming oligonucleotides fully modified with such nucleic acids constrained in the C3'-endo conformation considering that oligonucleotides fully modified with 2', 4'-BNA/LNA do not form triplexes.
引用
收藏
页码:3267 / 3273
页数:7
相关论文
共 50 条
  • [1] 2'-O,4'-C-ethylene-bridged nucleic acid (ENA™) for effective antisense formation
    Morita, K
    Yamate, K
    Kurakata, SI
    Watanabe, K
    Imanishi, T
    Koizumi, M
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2003, 22 (5-8): : 1619 - 1621
  • [2] Synthesis and properties of 2′-O,4′-C-ethylene-bridged nucleic acids (ENA) as effective antisense oligonucleotides
    Morita, K
    Takagi, M
    Hasegawa, C
    Kaneko, M
    Tsutsumi, S
    Sone, J
    Ishikawa, T
    Imanishi, T
    Koizumi, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (10) : 2211 - 2226
  • [3] 2′-O,4′-C-ethylene-bridged nucleic acids (ENA™) as next-generation antisense and antigene agents
    Koizumi, M
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (04) : 453 - 456
  • [4] Efficient Divergent Synthesis of 2′-O,4′-C-Ethylene-Bridged Nucleic Acid (ENA) Phosphoramidites
    Abe, Yuzo
    Ukai, Kazutoshi
    Michida, Makoto
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2022, 26 (04) : 1289 - 1307
  • [5] Development of Highly Efficient Divergent Synthesis for 2′-O,4′-C-Ethylene-bridged Nucleic Acid (ENA) Phosphoramidites
    Abe, Yuzo
    Ukai, Kazutoshi
    Michida, Makoto
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 2020, 78 (05) : 435 - 445
  • [6] 2′-O,4′-C-ethylene-bridged nucleic acids (ENA):: Highly nuclease-resistant and thermodynamically stable oligonucleotides for antisense drug
    Morita, K
    Hasegawa, C
    Kaneko, M
    Tsutsumi, S
    Sone, J
    Ishikawa, T
    Imanishi, T
    Koizumi, M
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (01) : 73 - 76
  • [7] Inhibition of VEGF mRNA by 2′-O,4′-C-ethylene-bridged nucleic acids (ENA®) antisense oligonucleotides and their influence on off-target gene expressions
    Morita, Koji
    Yamate, Koji
    Kurakata, Shin-ichi
    Abe, Koji
    Watanabe, Kenji
    Koizumi, Makoto
    Imanishi, Takeshi
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2006, 25 (4-6): : 503 - 521
  • [8] Enhancement of the inhibitory activity of oatp, antisense oligonucleotides by incorporation of 2′-O,4′-C-ethylene-bridged nucleic acids (ENA) without a loss of subtype selectivity
    Takagi, M
    Morita, K
    Nakai, D
    Nakagomi, R
    Tokui, T
    Koizumi, M
    BIOCHEMISTRY, 2004, 43 (15) : 4501 - 4510
  • [9] Development of Highly Efficient Divergent Synthesis for 2'-0,4'-C-Ethylene-bridged Nucleic Acid (ENA) Phosphoramidites
    Abe Y.
    Ukai K.
    Michida M.
    Yuki Gosei Kagaku Kyokaishi/Journal of Synthetic Organic Chemistry, 2020, 78 (05): : 435 - 445
  • [10] Synthesis of conformationally constrained 2′-N,4′-C-ethylene-bridged adenosine (aza-ENA-A)
    Wenska, Malgorzata
    Honcharenko, Dmytro
    Pathmasiri, Wimal
    Chattopadhyaya, Jyoti
    HETEROCYCLES, 2007, 73 (01) : 303 - +